A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico

The Perception of Celestamine Treatment in Mexico: a Retrospective Assessment of Consumer Perception of Prior Celestamine Use

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04645979

Enrollment

153

Registered

2020-11-27

Start date

2020-11-11

Completion date

2020-11-27

Last updated

2023-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinitis, Allergic

Brief summary

Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever. In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.

Interventions

OTHEROnline survey

Participants will be invited to complete an online questionnaire about their experience of product use.

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 50 Years

Healthy volunteers

Inclusion criteria

* Participants who used betamethasone plus loratadine within the previous 2 months for the treatment of acute episodes of allergic rhinitis * Participants allowing to use the data for research and marketing purposes as well as talking to authorities * Participants allowing us to use the pseudo-randomized individual data for further data analysis * Able to read and understand the language of the online questionnaire

Exclusion criteria

\- None

Design outcomes

Primary

Measure	Time frame	Description
Experience with betamethasone plus loratadine via an online questionnaire	2 months	Participants' experiences with betamethasone plus loratadine used under real life conditions.

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026